🔬 💊 𝗗𝗖𝗡 𝗖𝗼𝗿𝗽® | Nano-Tech for Equitable Innovation
At DCN Corp®, we’re committed to transforming nano-tech into accessible and life-enhancing solutions.
Our proprietary technology is validated to Technology Readiness Level 3 (TRL 3) and protected through an IP strategy.
🌐 What We Do: We believe we've developed a novel Surface Plasmon Resonance (SPR) process technology - translatable into next-gen diagnostic tool aiming to deliver real-time, quantifiable insights into biological conditions.
This innovation will evolve into a scalable, handheld bio-kit supporting early detection and precision diagnostics.
🎯 Our Mission: To pioneer the development and understanding of nano-tech applications that can positively impact humanity. Through rigorous research and sound science, we aim to demonstrate how nano-tech, especially in healthcare can lead to life-changing innovations.
👁️ Our Vision: We all know someone affected by serious illness - cancer, cardiovascular disease, or other life-altering conditions. These diseases respond better to treatment when detected early and accurately categorised. Our vision is to create a handheld diagnostic bio-kit that supports this goal, aligning with future trends in at-home rapid diagnostics.
📖 This vision is supported by leading research including the Science journal by Crosby et al. (2022), “Early Detection of Cancer”.
⚙️ SPR Tool Capabilities:-
✅ Real-time diagnostic results
✅ Quantitative severity analysis
✅ Compatibility with Raman & Infrared instruments (desktop & handheld)
🤝 What We Need To bring this vision to life, we’re actively seeking:-
🔧 Technical collaborations
💰 Financial partnerships
🎯 Our next R&D milestone: applying nano-tech to plastic polymer substrates to increase bio-sensitivity.
💸 We’re currently raising a pre-seed round of £500k+ ($677K+).
📩 If you're an investor, scientist, or partner interested in shaping the future of diagnostics, request our Executive Summary today.
Company Details
- Employees
- 3
- Founded
- -
- Address
- Ashton-Under-Lyne, Lan, Gb
- Industry
- Nanotechnology Research
- NAICS
-
Research and Development in Nanotechnology
- Website
- http://www.dcncorp.com
- Keywords
- Nanotechnology, Surface Enhancement Raman Scattering (SERS), Surface Plasmon Resonances (SPR), Nanoparticles, Raman spectroscopy, Industrial Research planning.
- HQ
- Ashton-under-Lyne, Lan
Dcn Corp® Questions
Dcn Corp®'s website is http://www.dcncorp.com
Dcn Corp®'s LinkedIn profile is https://uk.linkedin.com/company/dcncorp
Dcn Corp® has
3 employees.
View email and phone details for 3
employees at Dcn Corp®.
Dcn Corp®'s industry is
Nanotechnology Research
Dcn Corp®'s top competitors are
Midnight Health Ltd,
Kolabtree,
Nextgen Nano,
Centrix Pharma Solutions,
Nanosynth Group Plc,
Helmet Vision,
Graphitene Ltd.,
Odey Industrie Sarl,
Nano-Syn,
Hp1 Technologies.
Dcn Corp®'s categories are Nanotechnology Research
Dcn Corp®'s founding year is 2015
